ESC 365 - PRONOUNCE: comparing cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and cardiovascular disease

ESC Premium Access

PRONOUNCE: comparing cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and cardiovascular disease

Session: Hot Line - PRONOUNCE

Topic: Cardio-Oncology

Speaker: Professor R. Lopes (Durham, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

21 presentations

0 follower

2 more presentations in this session

PRONOUNCE - Discussant review.

Speaker: Professor T. Suter (Bern, CH)

PRONOUNCE - Panel discussion.

Access the full session

Hot Line - PRONOUNCE

Speakers: Professor R. Lopes, Professor T. Suter

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by